Brevan Howard Capital Management’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Brevan Howard Capital Management's ACLS Position: Q1 2026 in Review
Brevan Howard Capital Management reduced its Axcelis (ACLS) stake by 19% in Q1 2026, selling an estimated $79.2K and leaving 3,784 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #1524.
Brevan Howard Capital Management first reported a position in ACLS in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.32M in Q3 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Brevan Howard Capital Management held 3,784 shares of Axcelis worth $352K as of Q1 2026.
- Brevan Howard Capital Management sold 894 Axcelis shares in Q1 2026, an estimated $79.2K.
- Axcelis made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1524 holding.
- Brevan Howard Capital Management first reported a position in Axcelis in Q4 2023 and has held it in 8 quarters since.
- Brevan Howard Capital Management's Axcelis position peaked at $2.32M in Q3 2024.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.